Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator. | J Biol Chem;275(47): 36612-20, 2000 Nov 24. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.

Stewart, R J; Fredenburgh, J C; Rischke, J A; Bajzar, L; Weitz, J I.

Affiliation

Stewart RJ; Hamilton Civic Hospitals Research Centre and McMaster University, Hamilton, Ontario L8V 1C3, Canada.

J Biol Chem ; 275(47): 36612-20, 2000 Nov 24.

Article in En | MEDLINE | ID: mdl-10970891

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Fibrin Fibrinogen Degradation Products / Fibrin / Carboxypeptidases / Tissue Plasminogen Activator Limits: Humans Language: En Journal: J Biol Chem Year: 2000 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Fibrin Fibrinogen Degradation Products / Fibrin / Carboxypeptidases / Tissue Plasminogen Activator Limits: Humans Language: En Journal: J Biol Chem Year: 2000 Document type: Article Affiliation country: Country of publication: